Case Discussion: DMD

The France Foundation

C. Proud, A. Veerapandiyan, C. Mcdonald

DMD Management in the Era of Gene Therapy

The France Foundation

A. Veerapandiyan, C. Zaidman

Duchenne Muscular Dystrophy and Gene Therapy: What's On the Horizon?

The France Foundation

H. Abdel-Hamid, A. Veerapandiyan

Impact of Combination Therapies and Exercise Programs for Neuromuscu…

The France Foundation

A. Veerapandiyan, J. Brandsema, L. Servais

Emerging Therapies for Neuromuscular Diseases in 2021: ALS, Dystroph…

Houston Methodist

E. Greene

Current and Future Medical Treatment of Spinal Muscular Atrophy

International Congress on Early Onset Scoliosis and the Growing Spine (ICEOS)

R. Butterfield

Approach to a Child with Delayed Walking

UCSF School of Medicine

Y. Mitsuya

Neuromuscular Conditions Affecting Respiratory Muscles

NYU Langone

M. Y. Chu

Newborn Screening Programs: Development, Implementation, and the Roa…

Muscular Dystrophy Association

M. Caggana

Genetic Testing and Counseling for Neuromuscular Diseases

Muscular Dystrophy Association

L. Gutmann, S. Feely

The Technology Will See You Now: Digital Endpoints and AI Applicatio…

Henry J. Kaminski

Spinal Muscular Atrophy: Treatment Updates

NYU Langone

M. Y. Chu

Principles of AAV Gene Therapy for Inherited Neurological Disorders:…

American Neurological Association

S. G. Kaler, B. Traynor

Identification of Autonomic Cardiovascular Dysfunction in Adult SMA …

Silvia Bonanno

Newborn Screening for Duchenne Muscular Dystrophy

United Scientific Group

R. Rodney Howell

Pediatric Indications for Botulinum Toxin

UCSF School of Medicine

K. Sigford

Spinal Muscular Atrophy: Diagnosis and Treatment

ZINCARE

K. Lisa Nkole

Current Management of Spinal Muscular Atrophy

University of Miami

M. Saporta

SMA in 2022: Making It Up as We Go

International Congress on Early Onset Scoliosis and the Growing Spine (ICEOS)

P. Cahill

Cell-Based Therapies for Neuromuscular Diseases

Houston Methodist

B. Liao